PROTAGONIST THERAPEUTICS INC (PTGX) Stock Analyst Earnings Estimates
NASDAQ:PTGX - Nasdaq - US74366E1029 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 27.36M -4.44% | 26.58M -2.85% | 60M 125.73% | 327.2M 445.33% | 143.37M -56.18% | 119.31M -16.78% | 149.44M 25.25% | 306.47M 105.08% | 508.64M 65.97% | 680.85M 33.86% | 839.85M 23.35% | 1.019B 21.33% | |
| EBITDA YoY % growth | -125.04M -96.23% | -130.34M -4.24% | -92.675M 28.90% | 182.55M 296.98% | -86.437M -147.35% | 43.98M 150.88% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -125.85M -95.09% | -131.37M -4.39% | -93.652M 28.71% | 153.31M 263.70% | -66.817M -143.58% | -85.887M -28.54% | -79.482M 7.46% | 68.564M 186.26% | 254.09M 270.59% | 407.12M 60.23% | 535.76M 31.60% | 654.84M 22.23% | |
| Operating Margin | -459.98% | -494.24% | -156.09% | 46.86% | -46.60% | -71.99% | -53.19% | 22.37% | 49.95% | 59.80% | 63.79% | 64.26% | |
| EPS YoY % growth | -2.70 -33.66% | -2.60 3.70% | -1.49 42.69% | 2.72 282.62% | -1.48 -154.23% | -2.02 -36.59% | -1.22 39.38% | 0.70 156.93% | 3.34 380.06% | 5.50 64.63% | 7.80 41.87% | 9.21 18.09% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.33 -25.61% | 0.23 -92.81% | -0.58 -15.70% | -0.62 -14.82% | -0.45 -236.59% | -0.83 -451.95% | -0.90 -55.34% | -0.99 -59.41% | -1.06 -138.20% |
| Revenue Q2Q % growth | 51.36M -14.40% | 82.633M -67.59% | 10.187M 144.47% | 6.411M 37.13% | 29.376M -42.80% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 118.32M 392.47% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 17.94M -22.17% | 30.254M -85.34% | -35.761M 7.82% | -42.015M -1.36% | -16.501M -191.98% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.54 6.90% | -0.62 | 0.08 | 12.85% |
| Q2 2024 Q2Q % growth | -0.50 26.47% | -0.61 | 0.11 | 18.53% |
| Q1 2024 Q2Q % growth | 3.26 586.57% | 1.22 | 2.04 | 167.72% |
| Q4 2023 Q2Q % growth | 0.44 163.77% | -0.03 | 0.47 | 1,399.31% |
| Q3 2023 Q2Q % growth | -0.58 9.38% | -0.71 | 0.13 | 18.05% |
| Q2 2023 Q2Q % growth | -0.68 19.05% | -0.66 | -0.02 | -2.99% |
| Q1 2023 Q2Q % growth | -0.67 -55.81% | -0.74 | 0.07 | 9.61% |
| Q4 2022 Q2Q % growth | -0.69 10.39% | -0.65 | -0.04 | -5.98% |
| Q3 2022 Q2Q % growth | -0.64 8.57% | -0.89 | 0.25 | 27.71% |
| Q2 2022 Q2Q % growth | -0.84 -21.74% | -0.95 | 0.11 | 11.13% |
| Q1 2022 Q2Q % growth | -0.43 20.37% | -0.64 | 0.21 | 32.91% |
| Q4 2021 Q2Q % growth | -0.77 -60.42% | -0.80 | 0.03 | 3.53% |
| Q3 2021 Q2Q % growth | -0.70 -233.33% | -0.68 | -0.02 | -2.43% |
| Q2 2021 Q2Q % growth | -0.69 -13.11% | -0.56 | -0.13 | -23.64% |
| Q1 2021 Q2Q % growth | -0.54 25.00% | -0.58 | 0.04 | 6.79% |
| Q4 2020 Q2Q % growth | -0.48 23.81% | -0.49 | 0.01 | 1.55% |
| Q3 2020 Q2Q % growth | -0.21 65.57% | -0.62 | 0.41 | 66.39% |
| Q2 2020 Q2Q % growth | -0.61 48.31% | -0.61 | 0.00 | -0.51% |
| Q1 2020 Q2Q % growth | -0.72 -24.14% | -0.71 | -0.01 | -2.01% |
| Q4 2019 Q2Q % growth | -0.63 | -0.66 | 0.03 | 4.68% |
| Q3 2019 Q2Q % growth | -0.61 | -0.73 | 0.12 | 16.24% |
| Q2 2019 Q2Q % growth | -1.18 | -0.29 | -0.89 | -313.17% |
| Q1 2019 Q2Q % growth | -0.58 | -0.60 | 0.02 | 2.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 4.675M | 2.113M | 2.562M | 121.25% |
| Q2 2024 Q2Q % growth | 4.167M | 8.16M | -3.993M | -48.93% |
| Q1 2024 Q2Q % growth | 254.953M | 122.4M | 132.553M | 108.29% |
| Q4 2023 Q2Q % growth | 60M | 40.8M | 19.2M | 47.06% |
| Q3 2023 Q2Q % growth | 8.5M | -8.5M | -100.00% | |
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | -100.00% | 2.04M | -2.04M | -100.00% |
| Q4 2022 Q2Q % growth | -100.00% | 5.1M | -5.1M | -100.00% |
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | 860K -62.11% | 390.997K | 469.003K | 119.95% |
| Q1 2022 Q2Q % growth | 25.72M 315.51% | 17.391M | 8.329M | 47.89% |
| Q4 2021 Q2Q % growth | 8.62M 52.57% | 5.173M | 3.447M | 66.63% |
| Q3 2021 Q2Q % growth | 10.29M -21.51% | 1.778M | 8.512M | 478.74% |
| Q2 2021 Q2Q % growth | 2.27M -63.50% | 5.275M | -3.005M | -56.97% |
| Q1 2021 Q2Q % growth | 6.19M 69.59% | 1.53M | 4.66M | 304.58% |
| Q4 2020 Q2Q % growth | 5.65M 107.72% | 3.188M | 2.462M | 77.23% |
| Q3 2020 Q2Q % growth | 13.11M 216.67% | 2.193M | 10.917M | 497.81% |
| Q2 2020 Q2Q % growth | 6.22M 175.95% | 2.584M | 3.636M | 140.71% |
| Q1 2020 Q2Q % growth | 3.65M 133.97% | 1.51M | 2.14M | 141.72% |
| Q4 2019 Q2Q % growth | 2.72M | 3.29M | -570K | -17.33% |
| Q3 2019 Q2Q % growth | 4.14M | 4.923M | -783K | -15.90% |
| Q2 2019 Q2Q % growth | -8.19M | 11.424M | -19.614M | -171.69% |
| Q1 2019 Q2Q % growth | 1.56M | 5.003M | -3.443M | -68.82% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 468.25% | 350.13% | 7.42% | 34.85% |
| Revenue | 33.93% | 29.73% | 0.79% | 9.74% |